Abbott’s Blood Test For Traumatic Brain Injury Succeeds In Landmark Trial
Executive Summary
A landmark trial of Abbott Laboratories' point-of-care blood test for traumatic brain injuries shows the test could identify patients who should undergo magnetic resonance imaging (MRI), even after a computed tomography (CT) scan did not show a brain injury.